A screening algorithm for early detection of major depressive disorder in head and neck cancer patients post‐treatment: Longitudinal study. Issue 6 (19th April 2018) - Henry, Melissa
Abstract: Objective: The primary purpose of this study was to identify predictors of Major Depressive Disorder in head and neck cancer (HNC) patients in the immediate post‐treatment period (ie, at 3 months post‐diagnosis), with a focus on previously unexamined historical and contextual factors. Methods: Prospective longitudinal study of 223 consecutive adults (72% participation) newly diagnosed with a first occurrence of primary HNC, including validated psychometric measures, Structured Clinical Interviews for DSM Disorders, and medical chart reviews. Results: The 3‐month period prevalence of Major Depressive Disorder was 20.4%; with point prevalences of 6.8% upon HNC diagnosis, 14.2% at 3 months, and 22.6% lifetime. Patients most susceptible to developing Major Depressive Disorder in the immediate post‐treatment period: were diagnosed with advanced‐stage cancer rather than early‐stage cancer (O.R. = 4.94, P = 0.04), received surgery only (O.R. = 8.73, P = 0.04), presented a lifetime history of Anxiety Disorder on SCID‐I (O.R. = 6.62; P = 0.01), and indicated higher pre‐treatment levels of anxiety on the HADS (O.R. = 0.45, P = 0.05). Conclusions: Our results outline the predominant role of anxiety upon diagnosis as a precursor to post‐treatment Major Depressive Disorder, suggesting the need for identification and prophylactic treatment of anxiety upon diagnosis in head and neck cancer patients. Further investigation into pathways by which pre‐treatment anxiety predisposes to post‐treatment Major Depressive Disorder in this population is warranted.